{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:16:14Z","timestamp":1794438974775,"version":"4.9.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007156","name":"Innovation and Technology Commission - Hong Kong","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.eclinm.2025.103558","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T05:29:37Z","timestamp":1760074177000},"page":"103558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Antiseizure medications consumption in 73 countries and regions from 2012 to 2022: a longitudinal trend study"],"prefix":"10.1016","volume":"89","author":[{"given":"Adrienne Y.L.","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4850-566X","authenticated-orcid":false,"given":"Andrew S.C.","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7955-852X","authenticated-orcid":false,"given":"Yingfen","family":"Hsia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2320-0470","authenticated-orcid":false,"given":"Wallis C.Y.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Helen","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank M.C.","family":"Besag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anchor T.F.","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha","family":"Iessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neerja","family":"Chowdhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth K.C.","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8242-0014","authenticated-orcid":false,"given":"Ian C.K.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2025.103558_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116476","article-title":"Twenty-first century antiepileptic drugs. An overview of their targets and synthetic approaches","volume":"272","author":"S\u00e1nchez","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.eclinm.2025.103558_bib2","series-title":"Seizure Medications","author":"Subbarao","year":"2025"},{"issue":"10","key":"10.1016\/j.eclinm.2025.103558_bib3","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","article-title":"Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience","volume":"16","author":"Perucca","year":"2002","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103558_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2008.04.022","article-title":"Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts","volume":"81","author":"Meador","year":"2008","journal-title":"Epilepsy Res"},{"issue":"16","key":"10.1016\/j.eclinm.2025.103558_bib6","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.2013.2270","article-title":"Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism","volume":"309","author":"Christensen","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.eclinm.2025.103558_bib15","series-title":"Mental Health Gap Action Programme (mhGAP) Guideline for Mental, Neurological and Substance Use Disorders","year":"2023"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103558_bib16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s40264-020-00987-4","article-title":"Understanding and responding to prescribing patterns of sodium valproate-containing medicines in pregnant women and women of childbearing age in Western Cape, South Africa","volume":"44","author":"Mehta","year":"2021","journal-title":"Drug Saf"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103558_bib17","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.12680","article-title":"Prenatal exposure to valproic acid across various indications for use","volume":"7","author":"Smolinski","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"7","key":"10.1016\/j.eclinm.2025.103558_bib18","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s40264-023-01314-3","article-title":"Impact of 2018 EU risk minimisation measures and revised pregnancy prevention programme on utilisation and prescribing trends of medicinal products containing valproate: an interrupted time series study","volume":"46","author":"Abtahi","year":"2023","journal-title":"Drug Saf"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103558_bib19","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1528-1167.2009.02331.x","article-title":"Comparison of antiepileptic drug prescribing in children in three European countries","volume":"51","author":"Hsia","year":"2010","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.eclinm.2025.103558_bib20","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/adc.2008.144386","article-title":"Changing trends in antiepileptic drug prescribing in girls of child-bearing potential","volume":"94","author":"Ackers","year":"2009","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.eclinm.2025.103558_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.108450","article-title":"Prescription patterns and dosages of antiepileptic drugs in prevalent patients with epilepsy in Taiwan: a nationwide retrospective cross-sectional study","volume":"126","author":"Liang","year":"2022","journal-title":"Epilepsy Behav"},{"issue":"15","key":"10.1016\/j.eclinm.2025.103558_bib22","doi-asserted-by":"crossref","first-page":"E3463","DOI":"10.1073\/pnas.1717295115","article-title":"Global increase and geographic convergence in antibiotic consumption between 2000 and 2015","volume":"115","author":"Klein","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.eclinm.2025.103558_bib23","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/pds.1309","article-title":"Estimating national drug consumption using data at different points in the pharmaceutical supply chain","volume":"15","author":"Cook","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"10.1016\/j.eclinm.2025.103558_bib25","doi-asserted-by":"crossref","first-page":"e335","DOI":"10.1016\/S2468-2667(22)00013-5","article-title":"Global, regional, and national trends in opioid analgesic consumption from 2015 to 2019: a longitudinal study","volume":"7","author":"Ju","year":"2022","journal-title":"Lancet Public Health"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103558_bib26","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1038\/s41467-023-40637-8","article-title":"Gabapentinoid consumption in 65 countries and regions from 2008 to 2018: a longitudinal trend study","volume":"14","author":"Chan","year":"2023","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.eclinm.2025.103558_bib27","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S2215-0366(21)00292-3","article-title":"Psychotropic medicine consumption in 65 countries and regions, 2008-19: a longitudinal study","volume":"8","author":"Brauer","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.eclinm.2025.103558_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101780","article-title":"Attention-deficit\/hyperactivity disorder medication consumption in 64 countries and regions from 2015 to 2019: a longitudinal study","volume":"58","author":"Chan","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103558_bib30","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1016\/S2468-2667(24)00302-5","article-title":"Global, regional, and national burden of epilepsy, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"10","year":"2025","journal-title":"Lancet Public Health"},{"issue":"Suppl 7","key":"10.1016\/j.eclinm.2025.103558_bib31","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1528-1167.2011.03121.x","article-title":"Standards for epidemiologic studies and surveillance of epilepsy","volume":"52","author":"Thurman","year":"2011","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.eclinm.2025.103558_bib34","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S2215-0366(18)30293-1","article-title":"Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases","volume":"5","author":"Raman","year":"2018","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103558_bib35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"issue":"7624","key":"10.1016\/j.eclinm.2025.103558_bib37","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"von Elm","year":"2007","journal-title":"BMJ"},{"issue":"10177","key":"10.1016\/j.eclinm.2025.103558_bib38","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/S0140-6736(19)30344-7","article-title":"Venezuela's public health crisis: a regional emergency","volume":"393","author":"Page","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2025.103558_bib39","series-title":"Visit to the Bolivarian Republic of Venezuela - Report of the Special Rapporteur on the Negative Impact of unilateral Coercive Measures on the Enjoyment Of Human Rights","author":"Douhan","year":"2021"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103558_bib40","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/NRL.0000000000000522","article-title":"Trends in antiseizure medication prescribing among nursing home residents with and without a seizure diagnosis","volume":"28","author":"Winter","year":"2023","journal-title":"Neurologist"},{"issue":"4","key":"10.1016\/j.eclinm.2025.103558_bib42","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2471\/BLT.09.064147","article-title":"Global disparities in the epilepsy treatment gap: a systematic review","volume":"88","author":"Meyer","year":"2010","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.eclinm.2025.103558_bib43","series-title":"Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders","year":"2023"},{"key":"10.1016\/j.eclinm.2025.103558_bib44","series-title":"Epilepsy: A Public Health Imperative","year":"2019"},{"issue":"10067","key":"10.1016\/j.eclinm.2025.103558_bib45","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0140-6736(16)31599-9","article-title":"Essential medicines for universal health coverage","volume":"389","author":"Wirtz","year":"2017","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.eclinm.2025.103558_bib46","first-page":"329","article-title":"The history of barbiturates a century after their clinical introduction","volume":"1","author":"Lopez-Munoz","year":"2005","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.eclinm.2025.103558_bib47","series-title":"Phenytoin","author":"Gupta","year":"2025"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103558_bib48","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/ana.26561","article-title":"Comparative safety of antiseizure medication monotherapy for major malformations","volume":"93","author":"Cohen","year":"2023","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.eclinm.2025.103558_bib49","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/2042098611411127","article-title":"New generation antiepileptic drugs: what do they offer in terms of improved tolerability and safety?","volume":"2","author":"French","year":"2011","journal-title":"Ther Adv Drug Saf"},{"issue":"11","key":"10.1016\/j.eclinm.2025.103558_bib50","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S1474-4422(24)00376-4","article-title":"Equitable access to levetiracetam for people with epilepsy","volume":"23","author":"Sen","year":"2024","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.eclinm.2025.103558_bib52","series-title":"Improving Access to Medicines for Neurological Disorders","year":"2024"},{"issue":"23","key":"10.1016\/j.eclinm.2025.103558_bib53","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1056\/NEJMoa0907328","article-title":"Valproic acid monotherapy in pregnancy and major congenital malformations","volume":"362","author":"Jentink","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2025.103558_bib54","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.seizure.2014.08.008","article-title":"The outcomes of pregnancy in women with untreated epilepsy","volume":"24","author":"Vajda","year":"2015","journal-title":"Seizure"},{"issue":"9","key":"10.1016\/j.eclinm.2025.103558_bib55","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1212\/WNL.0000000000001304","article-title":"Antiepileptic drug use by pregnant women enrolled in Florida Medicaid","volume":"84","author":"Wen","year":"2015","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.eclinm.2025.103558_bib56","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1136\/jnnp-2017-317368","article-title":"Changing antiepilepsy drug-prescribing trends in women with epilepsy in the UK and Ireland and the impact on major congenital malformations","volume":"89","author":"Kinney","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.eclinm.2025.103558_bib57","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/epi.17526","article-title":"Impact of regulatory restrictions on the use of valproic acid in women of childbearing age: an Italian study","volume":"64","author":"Di Vito","year":"2023","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103558_bib59","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2165\/00023210-200620050-00003","article-title":"Management of epilepsy in women of childbearing age: practical recommendations","volume":"20","author":"Tettenborn","year":"2006","journal-title":"CNS Drugs"},{"issue":"9","key":"10.1016\/j.eclinm.2025.103558_bib60","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/jnnp-2020-323028","article-title":"Paternal exposure to antiepileptic drugs and offspring outcomes: a nationwide population-based cohort study in Sweden","volume":"91","author":"Tomson","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.eclinm.2025.103558_bib61","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.14709","article-title":"Valproate use during spermatogenesis and risk to offspring","volume":"7","author":"Christensen","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103558_bib62","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/jnnp-2024-334077","article-title":"Paternal exposure to antiseizure medications and offspring outcomes: a systematic review","volume":"96","author":"Honybun","year":"2024","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"10.1016\/j.eclinm.2025.103558_bib63","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jamaneurol.2022.1269","article-title":"Association of prenatal exposure to antiseizure medication with risk of autism and intellectual disability","volume":"79","author":"Bjork","year":"2022","journal-title":"JAMA Neurol"},{"issue":"10282","key":"10.1016\/j.eclinm.2025.103558_bib64","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(21)00246-4","article-title":"The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial","volume":"397","author":"Marson","year":"2021","journal-title":"Lancet"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537025004912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537025004912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T05:29:22Z","timestamp":1769059762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537025004912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":47,"alternative-id":["S2589537025004912"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103558","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiseizure medications consumption in 73 countries and regions from 2012 to 2022: a longitudinal trend study","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103558","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 World Health Organization; licensee Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103558"}}